Chemotherapy Options for the Elderly Patient with Advanced Non-Small Cell Lung Cancer

Chemotherapy Options for the Elderly Patient with Advanced Non-Small Cell Lung Cancer B.T. Hennessy, E.O. Hanrahan, O.S. Breathnach Oncologist 2003; 8: 270-277 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in lung cancer and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Describe the available clinical trial data of chemotherapy for advanced non-small-cell lung cancer in elderly patients. Compare older chemotherapy combinations with newer single agents in the treatment of advanced non-small-cell lung cancer. Identify reasons why elderly patients with lung cancer have been excluded from clinical trials. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: May 23, 2003 Most Recent Review: May 23, 2003* Most Recent Update: May 23, 2003 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.